Most stage 5 CKD patients have abnormal blood mineral levels and elevated levels of parathyroid hormone (PTH), a condition known as secondary hyperparathyroidism (SHPT) [4–6]. The gene discussed is PTH; the disease is secondary hyperparathyroidism.